Diabetic nephropathy and transforming growth factor-β: transforming our view of glomerulosclerosis and fibrosis build-up

This publication has 121 references indexed in Scilit:

• Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in db/db mice
  Biochemical and Biophysical Research Communications, 2003
• Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-β-induced fibronectin in mesangial cells
  Biochemical and Biophysical Research Communications, 2002
• Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy
  Medical Molecular Morphology, 2002
• Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria
  Nephrology Dialysis Transplantation, 2002
• In vitro evidence for differential involvement of CTGF, TGFβ, and PDGF‐BB in mesangial response to injury
  Nephrology Dialysis Transplantation, 2001
• GLUT1 and TGF-β: the link between hyperglycaemia and diabetic nephropathy
  Nephrology Dialysis Transplantation, 1999
• Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
  Hypertension, 1998
• Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
  Journal of Clinical Investigation, 1997
• Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
  Journal of Clinical Investigation, 1993
• Glomerular size and structure in diabetes mellitus. II. Late abnormalities
  Diabetologia, 1977